NAV
$8.99
AUM
$2.4M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| -10.17% | +9.38% | +4.01% | -13.33% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ISRG | Intuitive Surgical Inc | 12.99% |
| 2 | RMD | ResMed Inc | 10.92% |
| 3 | VEEV | Veeva Systems Inc Class A | 7.64% |
| 4 | GEHC | GE HealthCare Technologies Inc Common Stock | 7.33% |
| 5 | MRNA | Moderna Inc | 6.60% |
| 6 | IQV | IQVIA Holdings Inc | 6.54% |
| 7 | PHG | Koninklijke Philips NV ADR | 6.23% |
| 8 | PODD | Insulet Corp | 5.88% |
| 9 | DXCM | DexCom Inc | 5.09% |
| 10 | ZBH | Zimmer Biomet Holdings Inc | 4.16% |
Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.
Inception Date: 2024-01-11